After-Market: $164.01 +0.01 (0.01 %) 7:58 PM ET
ETF Quote Details
|NAV (month end)||155.89|
|Premium (+)/Discount (-) (month end)||+5.75|
Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.
This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:
See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs
ETF Expense Ratio
|Dividend (Yield)||$1.41 (0.88%)|
This Index is a subset of the Dow Jones U.S. Pharmaceuticals and Biotechnology Index which is a free-float adjusted market capitalization-weighted index.The Index measures the performance of the pharmaceuticals sector of the U.S. equity market.The Index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.
The iShares U.S. Pharmaceuticals ETF seeks investment results that correspond generally to the price and yield performance of Dow Jones U.S. Select Pharmaceuticals Index